FLGC vs. AADI, RENB, HYPD, RNXT, KLTO, EGRX, SNTI, LVTX, COEP, and ACRV
Should you be buying Flora Growth stock or one of its competitors? The main competitors of Flora Growth include Aadi Bioscience (AADI), Renovaro (RENB), Hyperion DeFi (HYPD), RenovoRx (RNXT), Klotho Neurosciences (KLTO), Eagle Pharmaceuticals (EGRX), Senti Biosciences (SNTI), LAVA Therapeutics (LVTX), Coeptis Therapeutics (COEP), and Acrivon Therapeutics (ACRV). These companies are all part of the "pharmaceutical products" industry.
Flora Growth vs. Its Competitors
Flora Growth (NASDAQ:FLGC) and Aadi Bioscience (NASDAQ:AADI) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.
Flora Growth has a beta of 1.97, suggesting that its share price is 97% more volatile than the S&P 500. Comparatively, Aadi Bioscience has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500.
36.0% of Flora Growth shares are owned by institutional investors. Comparatively, 52.1% of Aadi Bioscience shares are owned by institutional investors. 12.6% of Flora Growth shares are owned by company insiders. Comparatively, 37.3% of Aadi Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Flora Growth has higher revenue and earnings than Aadi Bioscience. Aadi Bioscience is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks.
In the previous week, Flora Growth had 1 more articles in the media than Aadi Bioscience. MarketBeat recorded 1 mentions for Flora Growth and 0 mentions for Aadi Bioscience. Flora Growth's average media sentiment score of 0.94 beat Aadi Bioscience's score of 0.00 indicating that Flora Growth is being referred to more favorably in the media.
Flora Growth has a net margin of -24.86% compared to Aadi Bioscience's net margin of -246.06%. Aadi Bioscience's return on equity of -71.87% beat Flora Growth's return on equity.
Flora Growth currently has a consensus price target of $93.00, suggesting a potential upside of 337.46%. Aadi Bioscience has a consensus price target of $1.75, suggesting a potential upside of 6.06%. Given Flora Growth's stronger consensus rating and higher possible upside, research analysts plainly believe Flora Growth is more favorable than Aadi Bioscience.
Summary
Flora Growth beats Aadi Bioscience on 11 of the 16 factors compared between the two stocks.
Get Flora Growth News Delivered to You Automatically
Sign up to receive the latest news and ratings for FLGC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding FLGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Flora Growth Competitors List
Related Companies and Tools
This page (NASDAQ:FLGC) was last updated on 8/22/2025 by MarketBeat.com Staff
MarketBeat All Access